Drug Recalls
RSS ↗2,059 drug recalls from federal enforcement feeds.
Showing 1,451–1,500 of 2,059
- Class II
Drug Recall · November 14, 2024
Ipana, 20% Benzocaine Topical Gel, 28g, Maxill Inc., St Thomas ON Canada.CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the mixing vessel. Product was to be rejected but was inadvertently released and shipped to customers.
- Class II
Drug Recall · November 14, 2024
UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323cGMP Deviations: the firm initiated a recall after notification from the distributor that product may be tainted with undeclared diclofenac and omeprazole, however there is no analytical data confirming that product distributed by the firm is tainted.
- Class II
Drug Recall · November 14, 2024
Amerisource Health Services LLC
Duloxetine Delayed-Release Capsules, USP, 20 mg, Rx only, 60 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-413-06CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit
- Class II
Drug Recall · November 13, 2024
Brands International Corporation
Kissable Diabetics Foot Cream, NET WT 4 oz (113 g) per tube, Manufactured By: Brands International Corp., Newmarket, ON, L3X 2S2. UPC 6 72008 80925 3CGMP Deviations: lack of adequate release testing.
- Class II
Drug Recall · November 11, 2024
Vitamin D3, 25 mcg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-104-01cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.
- Class II
Drug Recall · November 11, 2024
Venofer (iron sucrose) Injection, USP 100 mg Elemental Iron per 5 mL (20 mg/mL), 5 mL Single-Dose Vials, Rx Only, For Intravenous Use Only, Distributed by: Fresenius Medical Care NA, Waltham, MA 02451Presence of Particulate Matter: Potential for glass delamination from the vials.
- Class II
Drug Recall · November 11, 2024
Venofer (iron sucrose) Injection, USP 100 mg Elemental Iron per 5 mL (20 mg/mL), 5 mL Single-Dose Vials, Rx Only, For Intravenous Use Only, American Regent, Inc. Shirley, NY 11967, NDC: 0517-2340-01 (Presence of Particulate Matter: Potential for glass delamination from the vials.
- Class II
Drug Recall · November 11, 2024
Calcium Carbonate Chewable 500 mg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-106-01cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.
- Class II
Drug Recall · November 11, 2024
Docusate Sodium 250 mg, 1 Softgel in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-101-01cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.
- Class II
Drug Recall · November 11, 2024
Venofer (iron sucrose) Injection, USP 50 mg Elemental Iron per 2.5 mL (20 mg/mL), 2.5 mL Single-Dose Vials, Rx Only, For Intravenous Use Only, Distributed by: Fresenius Medical Care NA, Waltham, MA 02Presence of Particulate Matter: Potential for glass delamination from the vials.
- Class II
Drug Recall · November 11, 2024
Aspirin Chewable tablet 81 mg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-129-01cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.
- Class II
Drug Recall · November 11, 2024
Vitamin B1, 100 mcg, 1 tablet in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-108-01cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.
- Class II
Drug Recall · November 7, 2024
Cinacalcet Tablets, 60mg, packaged in: a) 30-count HDPE bottle (NDC 65862-832-30), b) 500-count HDPE bottle (NDC 65862-832-05), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-HightscGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit
- Class II
Drug Recall · November 7, 2024
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
Guaifenesin Dextromethorphan Syrup, 100 mg/10mg per 5 mL, Major Pharmaceuticals 8401 Bearing Drive, Suite 100, Indianapolis, IN, 46268, NDC 0904-7134-70Failed Impurity/Degradation Specifications
- Class II
Drug Recall · November 7, 2024
Cinacalcet Tablets, 30 mg, packaged in: a) 30-count HDPE bottle (NDC 65862-831-30); b) 500-count HDPE bottle (NDC 65862-831-05), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-HightcGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit
- Class II
Drug Recall · November 7, 2024
Cinacalcet Tablets, 90 mg, packaged in: a) 30-count HDPE bottle (NDC 65862-833-30), b) 500-count HDPE bottle (NDC 65862-833-05), Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-HightcGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit
- Class II
Drug Recall · November 7, 2024
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
Guaifenesin Dextromethorphan Syrup, 200 mg/20mg per 10 mL, Major Pharmaceuticals 8401 Bearing Drive, Suite 100, Indianapolis, IN, 46268, NDC 0904-7135-72Failed Impurity/Degradation Specifications
- Class II
Drug Recall · November 6, 2024
Genuine Joe Antibacterial Lotion Soap , Chloroxylenol 0.1%, 1 GALLON (3.78L), Manufactured in the U.S.A. for S.P. Richards Co., Atlanta, GA 30339cGMP Deviations: Out of specification results for micro in hand soap products.
- Class II
Drug Recall · November 6, 2024
MAXIM Assure Antibacterial, Chloroxylenol 0.1%, Net Contents: One U.S. Gallon (3.78 L), For Industrial and Institutional Use Only, MIDLAB 140 Private Brand Way, Athens, TN 37303cGMP Deviations: Out of specification results for micro in hand soap products.
- Class II
Drug Recall · November 6, 2024
ROYALAB Germ Away Antibacterial Hand Soap, Chloroxylenol 0.1%, NET CONTENTS: ONE U.S. GALLON (3.78 L), Royal Papers, 2701 Hereford St., St. Louis, MO 63139cGMP Deviations: Out of specification results for micro in hand soap products.
- Class II
Drug Recall · November 6, 2024
Trinity Gold Nutrition, 60 Capsule, 30 day Supply, Distributed by Trinity Gold Nutrition 201 Tom Hall St. Ste. 2107, Fortmill, SC 29716, USA, Ph: 704-629-8203, www.trinitygold.com, Made in India, UPCMarketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared acetaminophen, diclofenac and phenylbutazone.
- Class II
Drug Recall · November 6, 2024
Array Liquid Antiseptic Handwash, Chloroxylenol 0.1%, NET CONTENTS: 128 FL OZ (1 GAL) 3.785 L, FOR DISTRIBUTION EXCLUSIVELY BY GORDON FOOD SERVICE, WYOMING, MI 49509cGMP Deviations: Out of specification results for micro in hand soap products.
- Class II
Drug Recall · November 6, 2024
BEVACIZUMAB (AVASTIN)1.25mg/0.05mL, Sterile Injection, 0.5 mL Single-Dose Syringe, Rx Only, Repackaged by: Medivant Healthcare: 24416 N 19th Ave, Phoenix, AZ, NDC 81483-0041-1Lack of Sterility Assurance
- Class II
Drug Recall · November 6, 2024
boardwalk ANTIBACTERIAL HANDSOAP REFILL, Chloroxylenol 0.1%, 1 gal. (3.78 L), Manufactured for Essendant Co., One Parkway North, Deerfield, IL 60015cGMP Deviations: Out of specification results for micro in hand soap products.
- Class II
Drug Recall · November 6, 2024
Compliance Dishwashing Liquid & Antibacterial Soap, PCMX 0.1%, Net Contents: 1 Gallon, 128 Ounces, 3.785 Liters, Royal Corporation, 10232 Palm Drive, Santa Fe Springs, CA 90670cGMP Deviations: Out of specification results for micro in hand soap products.
- Class III
Drug Recall · November 5, 2024
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
Hydralazine HCl Tablets, USP, 25mg, Rx only, 100 tablets per carton, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, Distributed by: MAJOR Pharmaceuticals, Livonia, MI, 48152, USAFailed Impurities/Degradation Specifications; during routine stability testing for impurities.
- Class I
Drug Recall · November 4, 2024
PeakMax Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: PeakMax, San Francisco, CA, www.PeakMax.comMarketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.
- Class I
Drug Recall · November 4, 2024
ZapMax Capsules, 500 mg, 10 count blisters in cartons, Distributed by: ZapMax, 2108 N St. Sacramento, CA 95816, www.zapmax.comMarketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.
- Class I
Drug Recall · November 4, 2024
VitalityXtra Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: VitalityXtra, San Francisco, CA www.vitalityxtra.comMarketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.
- Class I
Drug Recall · November 4, 2024
ZoomMax Capsules, 500 mg, 10 count blisters in cartons, Distributed by: ZoomMax, 2108 N St. Sacramento, CA 95816, www.zoommax.comMarketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.
- Class II
Drug Recall · November 1, 2024
Cooling Menthol Extra Strength Pain Relief Patch, Menthol 7.5%, packaged in box of 5, Distributed by J.R. Watkins LLC, Oakland CA 94612 UPC 8 56294 00878 5, NDC 72342-100-05cGMP Deviations
- Class II
Drug Recall · November 1, 2024
Glenmark Pharmaceuticals Inc., USA
Diltiazem Hydrochloride Extended-Release Capsules, USP 90mg, Twice-a-Day Dosage, Rx Only, 100 Capsules per bottle, Mfd for: Northstar Rx LLC, Memphis, TN, Mfd by: Glenmark Pharmaceuticals Limited, PitcGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
- Class II
Drug Recall · November 1, 2024
Glenmark Pharmaceuticals Inc., USA
Diltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Rx Only, 100 Capsules, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, NDC 68462-562-01.cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
- Class II
Drug Recall · November 1, 2024
Glenmark Pharmaceuticals Inc., USA
Diltiazem Hydrochloride Extended-Release Capsules, USP 120mg, Twice-a-Day Dosage, Rx Only, 100 Capsules per bottle, Mfd for: Northstar Rx LLC, Memphis, TN, Mfd by: Glenmark Pharmaceuticals Limited, PicGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
- Class II
Drug Recall · November 1, 2024
Glenmark Pharmaceuticals Inc., USA
Diltiazem Hydrochloride Extended-Release Capsules, USP 60 mg, Twice-a-Day Dosage, Rx Only, 100 Capsules per bottle, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of IncGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
- Class II
Drug Recall · November 1, 2024
Glenmark Pharmaceuticals Inc., USA
Diltiazem Hydrochloride Extended-Release Capsules, USP 60 mg, Twice-a-Day Dosage, Rx Only, 100 Capsules per bottle, Mfd for: Northstar Rx LLC, Memphis, TN, Mfd by: Glenmark Pharmaceuticals Limited, PicGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
- Class II
Drug Recall · November 1, 2024
Glenmark Pharmaceuticals Inc., USA
Diltiazem Hydrochloride Extended-Release Capsules, USP 90 mg, Rx Only, 100 Capsules, Manufactured for : Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-851-01.cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
- Class II
Drug Recall · October 31, 2024
Xelstrym (dextroamphetamine) transdermal system, 13.5 mg dextroamphetamine/9 hours, 30 individually sealed transdermal patches, inside a foil-sealed polypropylene tray, packed in a paper carton/box, MDefective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive).
- Class II
Drug Recall · October 30, 2024
Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL), 5mL Single-Dose Pre-filled Syringe, Rx only, Manufactured by: Baxter Pharmaceutical Solutions, LLC, Bloomington, IN 47403; Manufactured for: Baxter HeaLabeling: Missing Label
- Class II
Drug Recall · October 29, 2024
Dapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-02.Crystallization
- Class II
Drug Recall · October 29, 2024
Timolol Maleate Ophthalmic Solution USP, 0.5%, Sterile, 5mL bottles, Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, Maharashtra, India, Distributed by: Rising Pharmaceuticals Inc, New JerseDefective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle
- Class III
Drug Recall · October 29, 2024
Dr. Reddy's Laboratories, Inc.
IBU (ibuprofen) 600 mg tablets, 500-count bottle, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, NDC 55111-683-05Failed Tablet/Capsule Specifications
- Class II
Drug Recall · October 25, 2024
Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, Distributed by: Lannet Company, Philadelphia, PA 19136, NDC: 0527-4661-37Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified content uniformity.
- Class II
Drug Recall · October 24, 2024
Unexo Life Sciences Private Limited
HealthWise PERIOD PATCH Menstrual Pain Relief, Menthol 10%, 10 patches per box, Manufactured for Veridian Healthcare, LLC, Gurnee, IL 60031 NDC 71101-947-10, UPC 8 45717 01072 6cGMP Deviations
- Class II
Drug Recall · October 24, 2024
Unexo Life Sciences Private Limited
THERACARE Cold Hot Medicated Patch, Menthol 5%, 5 patches per box, Manufactured for: Veridian Healthcare, LLC, Gurnee, IL 60031 NDC 71101-954-05, UPC 8 45717 00818 1cGMP Deviations
- Class II
Drug Recall · October 24, 2024
Unexo Life Sciences Private Limited
ABSORBINE jr. Extra Large BACK PATCH, Menthol 5%, 1 extra large patch per box, Distributed By: Absorbine Jr., LLC, Chattanooga, TN 37402 UPC 8 89476 41218 6, UPC 8 89476 41236 0cGMP Deviations